
    
      According to Global Initiative for Asthma treatment of asthma is based on avoidance of
      allergens, pharmacological treatment, and specific immunotherapy.

      The aim of the study is to assess the effect of specific immunotherapy (SIT) to dust mites on
      clinical symptoms, reliever drugs usage, inhaled glucocorticosteroid usage, quality of life,
      lung function, bronchial hyperreactivity with methacholine, and presence and type of allergy
      after three years of SIT in children with asthma.
    
  